Linda Nab

Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform

Linda Nab, Edward P K Parker, Colm Andrews et al. · The Lancet Public Health · 2023 · 97 citations · Full text

Public Health, Health Sciences, Infectious Diseases +12

Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform

Bang Zheng, Amelia Green, John Tazare et al. · BMJ · 2022 · 96 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT)

Oliver Carlile, Andrew Briggs, Alasdair D Henderson et al. · The Lancet Regional Health - Europe · 2024 · 96 citations · Full text

Pharmacy, Health Sciences, Clinical Epidemiology +16

Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY

Amelia Green, Helen J Curtis, Rose Higgins et al. · BMJ Medicine · 2023 · 37 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Approaches to addressing missing values, measurement error, and confounding in epidemiologic studies

Maarten van Smeden, Bas B. L. Penning de Vries, Linda Nab et al. · Journal of Clinical Epidemiology · 2020 · 31 citations · Full text

Public Health, Biostatistics, Causal Inference +16